Anna Turkova
Overview
Explore the profile of Anna Turkova including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
68
Citations
718
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
White E, Kityo C, Spyer M, Mujuru H, Nankya I, Kekitiinwa A, et al.
Lancet HIV
. 2025 Feb;
12(3):e201-e213.
PMID: 39978387
Background: ODYSSEY showed superior efficacy for dolutegravir-based antiretroviral therapy (ART) versus standard of care (SOC) in children living with HIV starting first-line or second-line ART aged 4 weeks or older....
2.
Eni-Olutu A, Eni-Olotu A, Mackie N, Glenn J, Bailey A, Bamford A, et al.
AIDS
. 2024 Oct;
39(3):276-280.
PMID: 39469738
Objective: The aim of this study was to identify the prevalence of emergent integrase drug resistance mutations (INSTI-DRMs) in international referrals to a perinatal virtual clinic (PVC). Design: A retrospective...
3.
Kamphuis A, Bamford A, Tagarro A, Cressey T, Bekker A, Amuge P, et al.
Paediatr Drugs
. 2024 Oct;
26(6):631-648.
PMID: 39436531
Treatment options for children living with HIV have historically been less effective, less practical and more difficult to implement compared with those for adults, as the research and development of...
4.
Jacobs T, Waalewijn H, Houlden L, Bollen P, Nanduudu A, Nambi E, et al.
Br J Clin Pharmacol
. 2024 Sep;
90(11):2947-2952.
PMID: 39228168
Dolutegravir (DTG) is primarily metabolized by uridine diphosphate glucuronosyltransferases, forming the pharmacologically inactive DTG glucuronide (DTG-gluc). We described the dolutegravir metabolic ratio (DTG-MR; DTG-gluc AUC divided by DTG AUC) in...
5.
Fritschi N, Gureva T, Eliseev P, Jackson C, Milanzi E, Crichton S, et al.
PLoS One
. 2024 Aug;
19(8):e0293272.
PMID: 39190640
Background: A novel skin test-called Diaskintest (DT)-containing specific M. tuberculosis antigens is in clinical use in the Russian Federation (RF). This test may improve diagnosis of tuberculosis (TB) infection. The...
6.
Bamford A, Hamzah L, Turkova A
Curr Opin HIV AIDS
. 2024 Jul;
19(6):323-329.
PMID: 38967797
Purpose Of Review: Universal antiretroviral (ART) coverage and virological suppression are fundamental to ending AIDS in children by 2030. Availability of new paediatric dolutegravir (DTG)-based ART formulations is a major...
7.
Turkova A, Chan M, Kityo C, Kekitiinwa A, Musoke P, Violari A, et al.
Contemp Clin Trials
. 2024 Apr;
142:107540.
PMID: 38636725
Background: There is increasing interest in utilising two-drug regimens for HIV treatment with the goal of reducing toxicity and improve acceptability. The D3 trial evaluates the efficacy and safety of...
8.
9.
Chabala C, Wobudeya E, van der Zalm M, Kapasa M, Raichur P, Mboizi R, et al.
Clin Infect Dis
. 2024 Apr;
79(1):70-77.
PMID: 38592950
Background: Children with human immunodeficiency virus (HIV, CWH) are at high risk of tuberculosis (TB) and face poor outcomes, despite antiretroviral therapy (ART). We evaluated outcomes in CWH and children...
10.
Makumbi S, Bajunirwe F, Ford D, Turkova A, South A, Lugemwa A, et al.
BMJ Open
. 2024 Mar;
14(3):e077546.
PMID: 38431301
Objectives: To examine the voluntariness of consent in paediatric HIV clinical trials and the associated factors. Design: Mixed-methods, cross-sectional study combining a quantitative survey conducted concurrently with indepth interviews. Setting...